DT
Draig Therapeutics at SfN 2026
Nov 14–18, 2026 Washington, DC ~21k attendees Website
Draig Therapeutics brings 2 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on preclinical drug candidates for cognition and anxiety. One thread explores a selective GABA A receptor modulator with anxiety-reducing effects and no sedation.
| Organization | SfN 2026 Attendance |
|---|---|
DT Draig Therapeutics Cardiff, UK | |
Biotechnology company developing therapies for neurological and psychiatric disorders in Cardiff, United Kingdom. | Poster Sat Nov 14 1–5pm |
Instantly find 20 buyers from Draig Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction